Immediate Impact
11 from Science/Nature 64 standout
Citing Papers
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Machine Learning Methods for Small Data Challenges in Molecular Science
2023 Standout
Works of Mark Morrow being referenced
Assessment of the biological and pharmacological effects of the ανβ3 and ανβ5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors
2007
Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark Morrow | 308 | 390 | 144 | 149 | 18 | 655 | |
| Dongpo Cai | 319 | 536 | 186 | 96 | 18 | 753 | |
| Jonathan Waxman | 254 | 312 | 66 | 267 | 14 | 627 | |
| Jieyi Wang | 288 | 433 | 100 | 335 | 27 | 834 | |
| Thomas Kryza | 257 | 251 | 54 | 157 | 32 | 626 | |
| Jeannette Bourguignon | 105 | 421 | 182 | 101 | 25 | 594 | |
| Donald P. Lesslie | 357 | 394 | 42 | 126 | 11 | 683 | |
| Lance Liotta | 250 | 441 | 226 | 177 | 13 | 779 | |
| Aizhen Xiao | 187 | 391 | 72 | 251 | 20 | 764 | |
| Danny Rickwood | 209 | 421 | 77 | 123 | 13 | 592 | |
| Edward H. van der Horst | 293 | 380 | 66 | 66 | 20 | 629 |
All Works
Loading papers...